Personalized Evidence-based Treatment in Patients With Invasive Breast Cancer
NCT ID: NCT04798976
Last Updated: 2021-03-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
3000 participants
OBSERVATIONAL
2021-03-01
2021-05-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neoadjuvant Chemotherapy in Breast Cancer
NCT04802941
Induction Preoperative Chemotherapy for Patients With Locally Advanced Triple Negative Breast Cancer
NCT01969032
The Neoadjuvant Combined Hormone Therapy in Premenopausal Women With Locally Advanced ER+/HER2- Breast Cancer
NCT04753177
PrefeRences And ChemoTherapy In Breast Cancer patiEnts
NCT06332976
HER2-low Unresectable and/or Metastatic Breast Cancer in Russia
NCT05913440
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CDSS (MedicBK) Analysis
neoadjuvant/adjuvant therapy
chemotherapy/endocrine therapy/surgery/radiotherapy
Core Laboratory Analysis
neoadjuvant/adjuvant therapy
chemotherapy/endocrine therapy/surgery/radiotherapy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
neoadjuvant/adjuvant therapy
chemotherapy/endocrine therapy/surgery/radiotherapy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
70 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Center for New Medical Technologies, Novosibirsk, Russia
OTHER
I.M. Sechenov First Moscow State Medical University
OTHER
Center of Personalized Medicine, Pirogova
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Evgeny Pokushalov
Director for research and development
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Evgeny Pokushalov
Novosibirsk, , Russia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Irina Ostanina, MD
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20210312
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.